13 Results for "

Human α-CGRP

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Human α-CGRP" in MCE Product Catalog:

12
12 Publications Verification
Referencia número: HY-15498
No. CAS: 1289023-67-1
Pureza:  99.94%
Synonyms: BMS-927711; BHV-3000
Target:  

CGRP Receptor

Áreas de investigación:  

Neurological Disease

Rimegepant (BMS-927711; BHV-3000) is an orally bioavailable and blood-brain barrier permeable antagonist of CGRP and AMY1 receptors, with a pIC50 of 8.01 and a Ki of 0.027 nM for human CGRP receptors. Rimegepant antagonizes cAMP production induced by αCGRP, βCGRP and amylin at CGRP and AMY1 receptors in humans, rats and mice, as well as at rat AMY3 receptors. Rimegepant can be used in research related to migraine .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-P1071
No. CAS: 90954-53-3
Synonyms: Calcitonin gene-related peptide
Target:  

CGRP Receptor

Áreas de investigación:  

Cardiovascular Disease

α-CGRP (human) (Calcitonin gene-related peptide) is a regulatory neuropeptide of 37 amino acids. α-CGRP (human) is widely distributed in the central and peripheral nervous system. α-CGRP (human) is a potent vasodilator and has inotropic and chronotropic effects .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-P1071A
Synonyms: Calcitonin gene-related peptide TFA
Target:  

CGRP Receptor

Áreas de investigación:  

Cardiovascular Disease

α-CGRP (human) (TFA) is a regulatory neuropeptide of 37 amino acids. α-CGRP (human) (TFA) is widely distributed in the central and peripheral nervous system. α-CGRP (human) (TFA) is a potent vasodilator and has inotropic and chronotropic effects .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-P1014
No. CAS: 119911-68-1
Synonyms: Human α-CGRP (8-37)
Target:  

CGRP Receptor

Áreas de investigación:  

Cardiovascular Disease

HCGRP-(8-37) (Human α-CGRP (8-37)) is a fragment of human calcitonin gene-related peptide (hCGRP) and an antagonist of the CGRP receptor, with an IC50 of 32.1 pM against the CGRP receptor. HCGRP-(8-37) blocks adenylate cyclase activation induced by CGRP receptor ligands and attenuates vascular responses triggered by CGRP. HCGRP-(8-37) reduces capsaicin-induced vasodilation in porcine nasal mucosa and superficial skin. HCGRP-(8-37) serves as a research tool to distinguish effects mediated by CGRP or calcitonin receptors, and to investigate CGRP-induced vascular effects .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P4058
No. CAS: 83652-28-2
Synonyms: CGRP free acid
Target:  

CGRP Receptor

Áreas de investigación:  

Neurological Disease

Calcitonin gene-related peptide (CGRP) free acid is a 37-amino acid neuropeptide, which represents the deamidated form of α-CGRP (human) (HY-P1071). Calcitonin gene-related peptide free acid is produced in the central and peripheral nervous systems of rats, and localizes to specific sensory, integrative and motor neuron systems, including those involved in nociception/thermoreception, feeding behavior, olfaction and visceral motor functions .
loading...
    loading...
Referencia número: HY-12366
No. CAS: 1374248-77-7
Pureza:  99.90%
Synonyms: MK-1602
Target:  

CGRP Receptor

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

Ubrogepant (MK-1602) is an orally active and selective antagonist of calcitonin gene-related peptide receptor (CGRP). Ubrogepant has high affinity for CGRP receptors in human and rhesus monkeys, and can effectively block the cAMP response stimulated by α-CGRP. Ubrogepant can be used in the study of acute migraine .
loading...
    loading...
Referencia número: HY-P99017
No. CAS: 1644539-04-7
Synonyms: ALD-403

Target:  

CGRP Receptor

Áreas de investigación:  

Neurological Disease

Eptinezumab (ALD-403) is a human monoclonal antibody targeting the α and β subtypes of human calcitonin gene-related peptide (CGRP). Eptinezumab binds to the CGRP ligand and blocks its binding to endogenous CGRP receptors, thereby inhibiting receptor activation. Eptinezumab can be used in research related to migraine .
loading...
    loading...
Referencia número: HY-P4946A
Target:  

Peptides

Áreas de investigación:  

Others

Biotinyl-α-CGRP (human) TFA is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
loading...
    loading...
Referencia número: HY-P4946
No. CAS: 1816258-60-2
Target:  

Peptides

Áreas de investigación:  

Others

Biotinyl-α-CGRP (human) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
loading...
    loading...
Referencia número: HY-P2601A
Target:  

CGRP Receptor

Áreas de investigación:  

Others

Tyr-α-CGRP (human) TFA is an N-terminally extended human α-CGRP analog. Tyr-α-CGRP (human) TFA can bind to membrane preparations from rat brain and spleen with IC50 values of 0.2 nM and 0.5 nM, respectively, and induce positive chronotropic and inotropic effects in isolated guinea pig right and left atria with EC50 values of 282 nM and 74 nM, respectively. Tyr-α-CGRP (human) TFA also inhibits contractile responses in rat vas deferens with an EC50 value of 1.9 nM .
loading...
    loading...
Referencia número: HY-12366R
No. CAS: 1374248-77-7
Synonyms: MK-1602 (Standard)
Ubrogepant (Standard) is the analytical standard of Ubrogepant. This product is intended for research and analytical applications. Ubrogepant (MK-1602) is an orally active and selective antagonist of calcitonin gene-related peptide receptor (CGRP). Ubrogepant has high affinity for CGRP receptors in human and rhesus monkeys, and can effectively block the cAMP response stimulated by α-CGRP. Ubrogepant can be used in the study of acute migraine .
loading...
    loading...
Referencia número: HY-12366S
Synonyms: MK-1602-d5
Ubrogepant-d5 (MK-1602-d5) is deuterium labeled Ubrogepant. Ubrogepant (MK-1602) is an orally active and selective antagonist of calcitonin gene-related peptide receptor (CGRP). Ubrogepant has high affinity for CGRP receptors in human and rhesus monkeys, and can effectively block the cAMP response stimulated by α-CGRP. Ubrogepant can be used in the study of acute migraine .
loading...
    loading...
Referencia número: HY-15498S
Synonyms: BMS-927711-d4; BHV-3000-d4
Rimegepant-d4 (BMS-927711-d4) is the deuterium labeled Rimegepant (HY-15498). Rimegepant (BMS-927711) is an orally bioavailable and blood-brain barrier permeable antagonist of CGRP and AMY1 receptors, with a pIC50 of 8.01 and a Ki of 0.027 nM for human CGRP receptors. Rimegepant antagonizes cAMP production induced by αCGRP, βCGRP and amylin at CGRP and AMY1 receptors in humans, rats and mice, as well as at rat AMY3 receptors. Rimegepant can be used in research related to migraine .
loading...
    loading...
  • 1